The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months.
  • onlinepersona@programming.dev
    71·
    2 days ago

    Known as VIZZ, from pharmaceutical company LENZ, the drops are an aceclidine ophthalmic solution that effectively treats presbyopia in adults. The once-daily drops offer relief from blurry near. vision for up to 10 hours.

    Presbyopia is an age related disease that affects the eye muscles impairing near vision as the muscles cannot contract enough to focus on things that are close. So this isn’t for myopia aka near sightedness.

    Anti Commercial-AI license